GSK plcGSKNYSE
Loading
EV to Sales HistoryNormalizing
Percentile Rank71
3Y CAGR+1.8%
5Y CAGR+4.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+1.8%/yr
vs -0.8%/yr prior
5Y CAGR
+4.2%/yr
Consistent
Acceleration
+2.5pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.70 | +24.3% |
| 2024 | 2.17 | -10.8% |
| 2023 | 2.43 | -5.0% |
| 2022 | 2.56 | -11.9% |
| 2021 | 2.91 | +32.6% |
| 2020 | 2.19 | -23.6% |
| 2019 | 2.87 | +8.7% |
| 2018 | 2.64 | +21.8% |
| 2017 | 2.17 | -19.6% |
| 2016 | 2.70 | - |